Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| 1 |
Parker-Hannifin
PH
|
$296M |
| 2 |
Microsoft
MSFT
|
$279M |
| 3 |
Union Pacific
UNP
|
$267M |
| 4 |
LLL
L3 Technologies, Inc.
LLL
|
$259M |
| 5 |
McDonald's
MCD
|
$254M |
Top Sells
| 1 |
Medtronic
MDT
|
$592M |
| 2 |
Apple
AAPL
|
$523M |
| 3 |
Amgen
AMGN
|
$457M |
| 4 |
General Dynamics
GD
|
$401M |
| 5 |
CSX Corp
CSX
|
$338M |
Sector Composition
| 1 | Technology | 23.95% |
| 2 | Healthcare | 14.99% |
| 3 | Financials | 13.93% |
| 4 | Industrials | 13.17% |
| 5 | Consumer Discretionary | 11.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
TMX
51
DELISTED
Terminix Global Holdings, Inc.
TMX
| $698M | 0.41% |
13,727,874
-270,984
| -2% | -$13.8M |
|
|
AGN
52
DELISTED
Allergan plc
AGN
| $692M | 0.41% |
4,110,356
-1,184,207
| -22% | -$199M |
|
53
Air Products & Chemicals
APD
$65B
| $691M | 0.41% |
4,347,503
+1,247,308
| +40% | +$198M |
|
54
Estee Lauder
EL
$32.7B
| $684M | 0.4% |
4,570,930
+248,444
| +6% | +$37.2M |
|
55
Coca-Cola
KO
$297B
| $679M | 0.4% |
15,623,187
+1,104,426
| +8% | +$48M |
|
56
Progressive
PGR
$144B
| $669M | 0.39% |
10,973,560
+936,852
| +9% | +$57.1M |
|
57
Amphenol
APH
$133B
| $656M | 0.39% |
7,615,430
-1,861,920
| -20% | -$160M |
|
58
Aon
AON
$80.2B
| $633M | 0.37% |
4,512,077
-51,832
| -1% | -$7.27M |
|
59
WEX
WEX
$5.79B
| $628M | 0.37% |
4,009,921
-27,850
| -0.7% | -$4.36M |
|
60
Aptiv
APTV
$17.1B
| $623M | 0.37% |
7,327,590
+577,831
| +9% | +$49.1M |
|
61
Neurocrine Biosciences
NBIX
$14.1B
| $619M | 0.36% |
7,463,994
+1,691,883
| +29% | +$140M |
|
|
AET
62
DELISTED
Aetna Inc
AET
| $618M | 0.36% |
3,655,888
-1,059,419
| -22% | -$179M |
|
63
LPL Financial
LPLA
$29B
| $601M | 0.35% |
9,838,347
+226,733
| +2% | +$13.8M |
|
64
NVIDIA
NVDA
$4.16T
| $597M | 0.35% |
2,578,360
+482,680
| +23% | +$112M |
|
|
NATI
65
DELISTED
National Instruments Corp
NATI
| $570M | 0.34% |
11,275,578
-25,652
| -0.2% | -$1.3M |
|
66
US Bancorp
USB
$75.5B
| $566M | 0.33% |
11,199,951
-366,129
| -3% | -$18.5M |
|
67
Nektar Therapeutics
NKTR
$553M
| $561M | 0.33% |
5,282,811
+1,477,497
| +39% | +$157M |
|
68
Sherwin-Williams
SHW
$90B
| $561M | 0.33% |
1,431,055
+127,554
| +10% | +$50M |
|
69
LyondellBasell Industries
LYB
$18B
| $560M | 0.33% |
5,296,481
+108,466
| +2% | +$11.5M |
|
70
Flex
FLEX
$20.1B
| $558M | 0.33% |
34,179,963
-278,423
| -0.8% | -$4.55M |
|
71
Amdocs
DOX
$9.29B
| $558M | 0.33% |
8,359,018
+813,361
| +11% | +$54.3M |
|
72
Gartner
IT
$19B
| $552M | 0.33% |
4,695,620
-223,024
| -5% | -$26.2M |
|
73
Illinois Tool Works
ITW
$76.4B
| $551M | 0.32% |
3,516,775
+38,964
| +1% | +$6.1M |
|
74
Regeneron Pharmaceuticals
REGN
$61.3B
| $551M | 0.32% |
1,599,434
-74,406
| -4% | -$25.6M |
|
75
Cimpress
CMPR
$1.53B
| $549M | 0.32% |
3,551,372
-406,334
| -10% | -$62.9M |
|